|
시장보고서
상품코드
1963761
백내장 치료 시장 : 시장 인사이트, 경쟁 구도 및 시장 예측(2033년)Cataract Treatment Market Insights, Competitive Landscape, and Market Forecast - 2033 |
||||||
세계 백내장 치료 시장 규모는 꾸준히 성장하고 있으며, 2026년에는 63억 달러, 2033년에는 94억 달러에 달할 것으로 예상됩니다. CAGR은 6.0%로 예상됩니다. 백내장 발병률의 증가와 더불어 안과 기술의 발전이 맞물리면서 전 세계 의료 현장에서 효과적인 치료법이 도입되고 있습니다.
시장 개요
백내장은 특히 50세 이상의 성인에서 시력 장애와 실명의 주요 원인 중 하나로 꼽히고 있습니다. 평균수명의 연장, 생활습관의 변화, 당뇨병과 같은 만성질환의 증가가 전 세계 백내장 발병률 상승에 기여하고 있습니다. 그 결과, 혁신적인 인공수정체(IOL)에서 최소침습 수술에 이르기까지 첨단 백내장 치료 솔루션에 대한 수요가 증가하고 있습니다.
초음파 유화흡입장치, 펨토초 레이저 보조 수술, 프리미엄 IOL 설계의 기술적 진보로 수술의 정확도가 향상되고 회복 시간이 단축되어 환자 만족도가 향상되었습니다. 의료 서비스 제공자들은 더 나은 치료 결과를 제공하고 늘어나는 환자군을 수용하기 위해 이러한 혁신 기술을 빠르게 도입하고 있습니다.
주요 시장 촉진요인
백내장 치료 시장의 성장을 이끄는 요인은 다음과 같습니다:
- 1. 고령화 : 전 세계 노인 인구의 증가는 특히 북미와 유럽에서 백내장 수술의 수요 증가를 직접적으로 촉진하고 있습니다.
- 2. 치료법 혁신 : 첨단 수술기구, 프리미엄 인공수정체, 안구 내 점탄제(OVD)의 개발로 백내장 수술의 효과와 안전성이 향상되고 있습니다.
- 3. 인지도 및 진단율 향상 : 공중보건 캠페인과 안과 의료 활동으로 조기 진단 및 치료가 촉진되어 잠재적 환자층이 확대되고 있습니다.
- 4. 외래 및 당일 치료로의 전환 : 안과 클리닉 및 외래 수술 센터의 보급이 확대되어 비용 대비 효과적이고 편리한 치료 옵션을 제공하고 있습니다.
- 5. 만성질환의 영향 : 백내장 형성에 기여하는 당뇨병 및 기타 만성질환의 증가로 인해 치료적 개입의 필요성이 증가하고 있습니다.
비즈니스 기회
백내장 치료 시장은 의료기기 제조업체, 안과 센터, 의료 서비스 제공자에게 큰 기회를 제공합니다. 아시아태평양 및 라틴아메리카의 신흥 경제국에서는 가처분 소득 증가, 의료 인프라 확충, 정부의 안과 의료 활성화 정책을 배경으로 현대적 안과 수술에 대한 수요가 증가하고 있습니다.
수술 계획 소프트웨어 및 원격 안과 플랫폼과 같은 디지털 기술은 수술의 정확성과 환자 관리를 향상시킬 수 있는 기회를 제공합니다. 또한, 주요 기업 간의 전략적 제휴, 합병 및 인수는 제품 포트폴리오를 확장하고 지리적 범위를 확장하는 길입니다.
지역별 전망
북미는 높은 의료비 지출, 첨단 의료기술의 도입, 그리고 높은 환자 인식으로 인해 세계 백내장 치료 시장을 선도하고 있습니다. 미국과 캐나다는 프리미엄 인공수정체(IOL) 및 최소침습 수술법 도입에 있어 앞서가고 있습니다.
유럽은 잘 구축된 안과 의료 인프라와 유리한 상환 정책으로 인해 성숙한 시장으로 자리매김하고 있습니다. 독일, 프랑스, 영국 등의 국가에서는 선진 치료법의 광범위한 채택으로 안정적인 성장을 보이고 있습니다.
아시아태평양은 고성장 시장으로 부상하고 있습니다. 인도, 중국, 일본 등의 국가에서 고령인구 증가, 의료비 지출 확대, 정부 주도의 안과 의료정책이 시장 확대를 뒷받침하고 있습니다.
라틴아메리카와 중동 및 아프리카는 신흥 시장으로 의료 인프라 개선, 인식 개선, 안과 의료 개선을 위한 국제 협력으로 백내장 치료에 대한 수요가 증가하고 있습니다.
경쟁 상황
백내장 치료 시장은 경쟁이 치열하며, 주요 세계 기업들은 혁신, 전략적 제휴, 지역 확장에 주력하고 있습니다. 주요 시장 진입 기업은 다음과 같습니다:
- Alcon Inc.
- Johnson & Johnson Vision(J&J Vision)
- Bausch + Lomb
- Carl Zeiss Meditec AG
- Hoya Corporation
- EssilorLuxottica
- Abbott Medical Optics(AMO)
- Novartis AG
- Glaukos Corporation
- NIDEK Co., Ltd.
- Oculus Optikgerate GmbH
- STAAR Surgical Company
- BVI(Bausch + Lomb Surgical)
- EyeKon Medical(Lensar)
- Shire
이들 기업은 혁신적인 제품 개발, 세계 입지 강화, 첨단 백내장 치료 솔루션에 대한 환자 수요 증가에 대응하기 위해 연구개발을 우선순위로 삼고 있습니다.
시장 세분화
백내장 치료 시장은 제품, 유형, 최종사용자, 지역별로 세분화됩니다:
제품별:
- 인공수정체(IOL)
- 안과용 점탄제(OVD)
- 초음파 유화흡입장치
- 기타
유형별:
- 장비
- 액세서리 및 소모품
최종사용자별:
- 병원
- 안과 클리닉
- 외래 수술 센터
- 기타
지역별:
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
목차
제1장 주요 요약
제2장 시장 개요
- 시장 정의와 세분화
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 시장 기회
- 밸류체인 분석
- COVID-19의 영향 분석
- Porter's Five Forces 분석
- 러시아·우크라이나 분쟁의 영향
- PESTLE 분석
- 규제 분석
- 가격 동향 분석
- 현재 가격과 향후 예측, 2025-2033년
- 가격 영향요인
제3장 세계의 백내장 치료 시장 전망, 2020-2033년
- 세계의 백내장 치료 시장 전망, 제품별, 금액(10억 달러), 2020-2033년
- 안내 렌즈(IOL)
- 안과용 점탄성 기기(OVD)
- 수정체유화 장비
- 기타
- 세계의 백내장 치료 시장 전망, 유형별, 금액(10억 달러), 2020-2033년
- 장비
- 액세서리와 소모품
- 세계의 백내장 치료 시장 전망, 최종사용자별, 금액(10억 달러), 2020-2033년
- 병원
- 안과 클리닉
- 외래 수술 센터
- 기타
- 세계의 백내장 치료 시장 전망, 지역별, 금액(10억 달러), 2020-2033년
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
제4장 북미의 백내장 치료 시장 전망, 2020-2033년
제5장 유럽의 백내장 치료 시장 전망, 2020-2033년
제6장 아시아태평양의 백내장 치료 시장 전망, 2020-2033년
제7장 라틴아메리카의 백내장 치료 시장 전망, 2020-2033년
제8장 중동 및 아프리카의 백내장 치료 시장 전망, 2020-2033년
제9장 경쟁 구도
- 기업 대 부문 히트맵
- 기업 시장 점유율 분석, 2025년
- 경쟁 대시보드
- 기업 개요
- Alcon Inc.
- Johnson & Johnson Vision(J&J Vision)
- Carl Zeiss Meditec AG
- Hoya Corporation
- EssilorLuxottica
- Abbott Medical Optics(AMO)
- Glaukos Corporation
- NIDEK Co., Ltd.
- Oculus Optikgerate GmbH
- STAAR Surgical Company
제10장 부록
KSM 26.03.24The global Cataract Treatment Market is experiencing steady growth, with the market expected to reach $6.3 billion in 2026 and expand to $9.4 billion by 2033, at a CAGR of 6.0%. Rising prevalence of cataracts, coupled with advances in ophthalmic technology, is driving the adoption of effective treatment options across healthcare settings worldwide.
Market Overview
Cataracts remain one of the leading causes of vision impairment and blindness, particularly among adults aged 50 years and above. Increasing life expectancy, lifestyle changes, and higher rates of chronic conditions such as diabetes have contributed to the rising incidence of cataracts globally. As a result, there is growing demand for advanced cataract treatment solutions, ranging from innovative intraocular lenses (IOLs) to minimally invasive surgical procedures.
Technological advancements in phacoemulsification equipment, femtosecond laser-assisted surgery, and premium IOL designs have improved surgical precision, reduced recovery times, and enhanced patient satisfaction. Healthcare providers are rapidly adopting these innovations to deliver better outcomes and cater to an expanding patient population.
Key Market Drivers
Several factors are propelling growth in the cataract treatment market:
- 1. Aging Population: The global increase in elderly populations is directly driving higher demand for cataract surgeries, particularly in North America and Europe.
- 2. Innovation in Treatment Options: The development of advanced surgical tools, premium IOLs, and ophthalmic viscoelastic devices (OVDs) is improving the efficacy and safety of cataract procedures.
- 3. Rising Awareness and Diagnosis: Public health campaigns and eye care initiatives are encouraging early diagnosis and treatment, expanding the potential patient base.
- 4. Shift to Ambulatory and Outpatient Care: Increasing adoption of ophthalmology clinics and ambulatory surgery centers is providing cost-effective and convenient treatment options.
- 5. Impact of Chronic Diseases: A rise in diabetes and other chronic conditions that contribute to cataract formation is increasing the need for treatment interventions.
Business Opportunities
The cataract treatment market presents significant opportunities for device manufacturers, ophthalmology centers, and healthcare providers. Emerging economies in the Asia Pacific and Latin America are witnessing increased demand for modern ophthalmic procedures, driven by rising disposable incomes, expanding healthcare infrastructure, and government initiatives promoting eye care.
Digital technologies, including surgical planning software and teleophthalmology platforms, offer opportunities to enhance surgical precision and patient management. Additionally, strategic partnerships, mergers, and acquisitions among leading companies provide avenues for expanding product portfolios and increasing geographic reach.
Regional Outlook
North America dominates the global cataract treatment market, owing to high healthcare expenditure, advanced medical technology adoption, and strong patient awareness. The United States and Canada lead in the use of premium IOLs and minimally invasive surgical procedures.
Europe remains a mature market with established ophthalmic infrastructure and favorable reimbursement policies. Countries such as Germany, France, and the UK are witnessing stable growth due to the wide adoption of advanced treatment modalities.
The Asia Pacific region is emerging as a high-growth market. Increasing geriatric populations, rising healthcare spending, and government-led eye care initiatives in countries such as India, China, and Japan are supporting market expansion.
Latin America and the Middle East & Africa represent emerging markets with growing demand for cataract treatments, supported by improving healthcare infrastructure, rising awareness, and international collaborations to enhance ophthalmic care.
Competitive Landscape
The cataract treatment market is highly competitive, with leading global players focusing on innovation, strategic collaborations, and regional expansion. Key market participants include:
- Alcon Inc.
- Johnson & Johnson Vision (J&J Vision)
- Bausch + Lomb (a division of Bausch Health Companies Inc.)
- Carl Zeiss Meditec AG
- Hoya Corporation
- EssilorLuxottica
- Abbott Medical Optics (AMO)
- Novartis AG (Alcon formerly part; related products)
- Glaukos Corporation
- NIDEK Co., Ltd.
- Oculus Optikgerate GmbH
- STAAR Surgical Company
- BVI (Bausch + Lomb Surgical)
- EyeKon Medical (Lensar)
- Shire
These companies are prioritizing R&D to develop innovative products, strengthen their global presence, and meet the growing patient demand for advanced cataract treatment solutions.
Market Segmentation
The cataract treatment market is segmented into products, types, end-users, and regions:
By Product:
- Intraocular Lenses (IOLs)
- Ophthalmic Viscoelastic Devices (OVDs)
- Phacoemulsification Equipment
- Others
By Type:
- Equipment
- Accessories & Consumables
By End-user:
- Hospitals
- Ophthalmology Clinics
- Ambulatory Surgery Centres
- Others
By Region:
- North America
- Europe
- The Asia Pacific
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Cataract Treatment Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Five Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Cataract Treatment Market Outlook, 2020 - 2033
- 3.1. Global Cataract Treatment Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 3.1.1. Intraocular Lenses (IOLs)
- 3.1.2. Ophthalmic Viscoelastic Devices (OVDs)
- 3.1.3. Phacoemulsification Equipment
- 3.1.4. Others
- 3.2. Global Cataract Treatment Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 3.2.1. Equipment
- 3.2.2. Accessories & Consumables
- 3.3. Global Cataract Treatment Market Outlook, by End-user, Value (US$ Bn), 2020-2033
- 3.3.1. Hospitals
- 3.3.2. Ophthalmology Clinics
- 3.3.3. Ambulatory Surgery Centres
- 3.3.4. Others
- 3.4. Global Cataract Treatment Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.4.1. North America
- 3.4.2. Europe
- 3.4.3. Asia Pacific
- 3.4.4. Latin America
- 3.4.5. Middle East & Africa
4. North America Cataract Treatment Market Outlook, 2020 - 2033
- 4.1. North America Cataract Treatment Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 4.1.1. Intraocular Lenses (IOLs)
- 4.1.2. Ophthalmic Viscoelastic Devices (OVDs)
- 4.1.3. Phacoemulsification Equipment
- 4.1.4. Others
- 4.2. North America Cataract Treatment Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 4.2.1. Equipment
- 4.2.2. Accessories & Consumables
- 4.3. North America Cataract Treatment Market Outlook, by End-user, Value (US$ Bn), 2020-2033
- 4.3.1. Hospitals
- 4.3.2. Ophthalmology Clinics
- 4.3.3. Ambulatory Surgery Centres
- 4.3.4. Others
- 4.4. North America Cataract Treatment Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.4.1. U.S. Cataract Treatment Market Outlook, by Product, 2020-2033
- 4.4.2. U.S. Cataract Treatment Market Outlook, by Type, 2020-2033
- 4.4.3. U.S. Cataract Treatment Market Outlook, by End-user, 2020-2033
- 4.4.4. Canada Cataract Treatment Market Outlook, by Product, 2020-2033
- 4.4.5. Canada Cataract Treatment Market Outlook, by Type, 2020-2033
- 4.4.6. Canada Cataract Treatment Market Outlook, by End-user, 2020-2033
- 4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Cataract Treatment Market Outlook, 2020 - 2033
- 5.1. Europe Cataract Treatment Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 5.1.1. Intraocular Lenses (IOLs)
- 5.1.2. Ophthalmic Viscoelastic Devices (OVDs)
- 5.1.3. Phacoemulsification Equipment
- 5.1.4. Others
- 5.2. Europe Cataract Treatment Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 5.2.1. Equipment
- 5.2.2. Accessories & Consumables
- 5.3. Europe Cataract Treatment Market Outlook, by End-user, Value (US$ Bn), 2020-2033
- 5.3.1. Hospitals
- 5.3.2. Ophthalmology Clinics
- 5.3.3. Ambulatory Surgery Centres
- 5.3.4. Others
- 5.4. Europe Cataract Treatment Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.4.1. Germany Cataract Treatment Market Outlook, by Product, 2020-2033
- 5.4.2. Germany Cataract Treatment Market Outlook, by Type, 2020-2033
- 5.4.3. Germany Cataract Treatment Market Outlook, by End-user, 2020-2033
- 5.4.4. Italy Cataract Treatment Market Outlook, by Product, 2020-2033
- 5.4.5. Italy Cataract Treatment Market Outlook, by Type, 2020-2033
- 5.4.6. Italy Cataract Treatment Market Outlook, by End-user, 2020-2033
- 5.4.7. France Cataract Treatment Market Outlook, by Product, 2020-2033
- 5.4.8. France Cataract Treatment Market Outlook, by Type, 2020-2033
- 5.4.9. France Cataract Treatment Market Outlook, by End-user, 2020-2033
- 5.4.10. U.K. Cataract Treatment Market Outlook, by Product, 2020-2033
- 5.4.11. U.K. Cataract Treatment Market Outlook, by Type, 2020-2033
- 5.4.12. U.K. Cataract Treatment Market Outlook, by End-user, 2020-2033
- 5.4.13. Spain Cataract Treatment Market Outlook, by Product, 2020-2033
- 5.4.14. Spain Cataract Treatment Market Outlook, by Type, 2020-2033
- 5.4.15. Spain Cataract Treatment Market Outlook, by End-user, 2020-2033
- 5.4.16. Russia Cataract Treatment Market Outlook, by Product, 2020-2033
- 5.4.17. Russia Cataract Treatment Market Outlook, by Type, 2020-2033
- 5.4.18. Russia Cataract Treatment Market Outlook, by End-user, 2020-2033
- 5.4.19. Rest of Europe Cataract Treatment Market Outlook, by Product, 2020-2033
- 5.4.20. Rest of Europe Cataract Treatment Market Outlook, by Type, 2020-2033
- 5.4.21. Rest of Europe Cataract Treatment Market Outlook, by End-user, 2020-2033
- 5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Cataract Treatment Market Outlook, 2020 - 2033
- 6.1. Asia Pacific Cataract Treatment Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 6.1.1. Intraocular Lenses (IOLs)
- 6.1.2. Ophthalmic Viscoelastic Devices (OVDs)
- 6.1.3. Phacoemulsification Equipment
- 6.1.4. Others
- 6.2. Asia Pacific Cataract Treatment Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 6.2.1. Equipment
- 6.2.2. Accessories & Consumables
- 6.3. Asia Pacific Cataract Treatment Market Outlook, by End-user, Value (US$ Bn), 2020-2033
- 6.3.1. Hospitals
- 6.3.2. Ophthalmology Clinics
- 6.3.3. Ambulatory Surgery Centres
- 6.3.4. Others
- 6.4. Asia Pacific Cataract Treatment Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.4.1. China Cataract Treatment Market Outlook, by Product, 2020-2033
- 6.4.2. China Cataract Treatment Market Outlook, by Type, 2020-2033
- 6.4.3. China Cataract Treatment Market Outlook, by End-user, 2020-2033
- 6.4.4. Japan Cataract Treatment Market Outlook, by Product, 2020-2033
- 6.4.5. Japan Cataract Treatment Market Outlook, by Type, 2020-2033
- 6.4.6. Japan Cataract Treatment Market Outlook, by End-user, 2020-2033
- 6.4.7. South Korea Cataract Treatment Market Outlook, by Product, 2020-2033
- 6.4.8. South Korea Cataract Treatment Market Outlook, by Type, 2020-2033
- 6.4.9. South Korea Cataract Treatment Market Outlook, by End-user, 2020-2033
- 6.4.10. India Cataract Treatment Market Outlook, by Product, 2020-2033
- 6.4.11. India Cataract Treatment Market Outlook, by Type, 2020-2033
- 6.4.12. India Cataract Treatment Market Outlook, by End-user, 2020-2033
- 6.4.13. Southeast Asia Cataract Treatment Market Outlook, by Product, 2020-2033
- 6.4.14. Southeast Asia Cataract Treatment Market Outlook, by Type, 2020-2033
- 6.4.15. Southeast Asia Cataract Treatment Market Outlook, by End-user, 2020-2033
- 6.4.16. Rest of SAO Cataract Treatment Market Outlook, by Product, 2020-2033
- 6.4.17. Rest of SAO Cataract Treatment Market Outlook, by Type, 2020-2033
- 6.4.18. Rest of SAO Cataract Treatment Market Outlook, by End-user, 2020-2033
- 6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Cataract Treatment Market Outlook, 2020 - 2033
- 7.1. Latin America Cataract Treatment Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 7.1.1. Intraocular Lenses (IOLs)
- 7.1.2. Ophthalmic Viscoelastic Devices (OVDs)
- 7.1.3. Phacoemulsification Equipment
- 7.1.4. Others
- 7.2. Latin America Cataract Treatment Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 7.2.1. Equipment
- 7.2.2. Accessories & Consumables
- 7.3. Latin America Cataract Treatment Market Outlook, by End-user, Value (US$ Bn), 2020-2033
- 7.3.1. Hospitals
- 7.3.2. Ophthalmology Clinics
- 7.3.3. Ambulatory Surgery Centres
- 7.3.4. Others
- 7.4. Latin America Cataract Treatment Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.4.1. Brazil Cataract Treatment Market Outlook, by Product, 2020-2033
- 7.4.2. Brazil Cataract Treatment Market Outlook, by Type, 2020-2033
- 7.4.3. Brazil Cataract Treatment Market Outlook, by End-user, 2020-2033
- 7.4.4. Mexico Cataract Treatment Market Outlook, by Product, 2020-2033
- 7.4.5. Mexico Cataract Treatment Market Outlook, by Type, 2020-2033
- 7.4.6. Mexico Cataract Treatment Market Outlook, by End-user, 2020-2033
- 7.4.7. Argentina Cataract Treatment Market Outlook, by Product, 2020-2033
- 7.4.8. Argentina Cataract Treatment Market Outlook, by Type, 2020-2033
- 7.4.9. Argentina Cataract Treatment Market Outlook, by End-user, 2020-2033
- 7.4.10. Rest of LATAM Cataract Treatment Market Outlook, by Product, 2020-2033
- 7.4.11. Rest of LATAM Cataract Treatment Market Outlook, by Type, 2020-2033
- 7.4.12. Rest of LATAM Cataract Treatment Market Outlook, by End-user, 2020-2033
- 7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Cataract Treatment Market Outlook, 2020 - 2033
- 8.1. Middle East & Africa Cataract Treatment Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 8.1.1. Intraocular Lenses (IOLs)
- 8.1.2. Ophthalmic Viscoelastic Devices (OVDs)
- 8.1.3. Phacoemulsification Equipment
- 8.1.4. Others
- 8.2. Middle East & Africa Cataract Treatment Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 8.2.1. Equipment
- 8.2.2. Accessories & Consumables
- 8.3. Middle East & Africa Cataract Treatment Market Outlook, by End-user, Value (US$ Bn), 2020-2033
- 8.3.1. Hospitals
- 8.3.2. Ophthalmology Clinics
- 8.3.3. Ambulatory Surgery Centres
- 8.3.4. Others
- 8.4. Middle East & Africa Cataract Treatment Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.4.1. GCC Cataract Treatment Market Outlook, by Product, 2020-2033
- 8.4.2. GCC Cataract Treatment Market Outlook, by Type, 2020-2033
- 8.4.3. GCC Cataract Treatment Market Outlook, by End-user, 2020-2033
- 8.4.4. South Africa Cataract Treatment Market Outlook, by Product, 2020-2033
- 8.4.5. South Africa Cataract Treatment Market Outlook, by Type, 2020-2033
- 8.4.6. South Africa Cataract Treatment Market Outlook, by End-user, 2020-2033
- 8.4.7. Egypt Cataract Treatment Market Outlook, by Product, 2020-2033
- 8.4.8. Egypt Cataract Treatment Market Outlook, by Type, 2020-2033
- 8.4.9. Egypt Cataract Treatment Market Outlook, by End-user, 2020-2033
- 8.4.10. Nigeria Cataract Treatment Market Outlook, by Product, 2020-2033
- 8.4.11. Nigeria Cataract Treatment Market Outlook, by Type, 2020-2033
- 8.4.12. Nigeria Cataract Treatment Market Outlook, by End-user, 2020-2033
- 8.4.13. Rest of Middle East Cataract Treatment Market Outlook, by Product, 2020-2033
- 8.4.14. Rest of Middle East Cataract Treatment Market Outlook, by Type, 2020-2033
- 8.4.15. Rest of Middle East Cataract Treatment Market Outlook, by End-user, 2020-2033
- 8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Alcon Inc.
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Johnson & Johnson Vision (J&J Vision)
- 9.4.3. Carl Zeiss Meditec AG
- 9.4.4. Hoya Corporation
- 9.4.5. EssilorLuxottica
- 9.4.6. Abbott Medical Optics (AMO)
- 9.4.7. Glaukos Corporation
- 9.4.8. NIDEK Co., Ltd.
- 9.4.9. Oculus Optikgerate GmbH
- 9.4.10. STAAR Surgical Company
- 9.4.1. Alcon Inc.
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
